Veritas Shoulder System

K260556 · Restor3D · PHX · Jul 1, 2026 · Orthopedic

Device Facts

Record IDK260556
Device NameVeritas Shoulder System
ApplicantRestor3D
Product CodePHX · Orthopedic
Decision DateJul 1, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3660
Device ClassClass 2
AttributesTherapeutic

Indications for Use

Reverse Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The Veritas Reverse Total Shoulder System standard components are indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. The Veritas system's patient specific components are only indicated for primary total shoulder replacement. Glenoid component with porous surface is indicated for uncemented application with the addition of screw fixation. Note: A CT scan is used to create the Veritas patient specific components Hemiarthroplasty Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for: - Advanced wear and tear of the shoulder joint resulting from degenerative, post-traumatic, or rheumatoid arthritis if adequate bone stock is present. - Avascular Necrosis - Conditions consequent to earlier operations Humeral components with porous surface are indicated for either cemented or uncemented applications.

Device Story

Veritas Shoulder System is a shoulder arthroplasty system; includes humeral head and adapter plate components; designed to mate with previously cleared humeral stem (K243643). System utilizes patient-specific components created from CT scan data; includes off-the-shelf components for hemiarthroplasty. Used by surgeons in clinical settings to treat shoulder joint pathology; provides mechanical replacement of joint surfaces to relieve pain and restore function. Adapter plate features self-locking male tapers for assembly. System includes supporting instrumentation for surgical implantation.

Clinical Evidence

Bench testing only. Performance testing included axial taper disassembly strength (ASTM F2009), torsional taper disassembly strength, humeral stem fatigue, and fretting/corrosion testing.

Technological Characteristics

Shoulder joint metal/polymer semi-constrained cemented prosthesis. Features self-locking male tapers. Components include adapter plate and anatomic humeral head. Porous surface options for uncemented application with screw fixation. Testing performed per ASTM F2009.

Indications for Use

Indicated for patients with grossly deficient rotator cuff and severe arthropathy, failed prior shoulder replacement, advanced degenerative/post-traumatic/rheumatoid arthritis, avascular necrosis, or conditions from prior operations. Requires functional deltoid muscle and adequate bone stock. Patient-specific components limited to primary total shoulder replacement.

Regulatory Classification

Identification

A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).

Special Controls

*Classification.* Class II. The special controls for this device are:(1) FDA's: (i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ” (ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),” (iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,” (iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and (v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,” (2) International Organization for Standardization's (ISO): (i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,” (ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,” (iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,” (iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,” (v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,” (vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and (vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and (3) American Society for Testing and Materials': (i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,” (ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,” (iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,” (iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,” (v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,” (vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,” (vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and (viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”

Predicate Devices

Reference Devices

Submission Summary (Full Text)

{0} **U.S. FOOD & DRUG** ADMINISTRATION July 1, 2026 Restor3D Knox Pittman Regulatory Engineer 4001 Nc-54 Hwy. Suite 2160 Durham, North Carolina 27709 Re: K260556 Trade/Device Name: Veritas Shoulder System Regulation Number: 21 CFR 888.3660 Regulation Name: Shoulder joint metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: PHX, HSD Dated: June 3, 2026 Received: June 4, 2026 Dear Knox Pittman: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1} K260556 - Knox Pittman Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the {2} K260556 - Knox Pittman Page 3 Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, FARZANA SHARMIN -S Farzana Sharmin, PhD. Assistant Director DHT6A: Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below Submission Number (if known) K260556 Device Name Veritas Shoulder System Indications for Use (Describe) Reverse Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The Veritas Reverse Total Shoulder System standard components are indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. The Veritas system's patient specific components are only indicated for primary total shoulder replacement. Glenoid component with porous surface is indicated for uncemented application with the addition of screw fixation. Note: A CT scan is used to create the Veritas patient specific components Hemiarthroplasty Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for: - Advanced wear and tear of the shoulder joint resulting from degenerative, post-traumatic, or rheumatoid arthritis if adequate bone stock is present. - Avascular Necrosis - Conditions consequent to earlier operations Humeral components with porous surface are indicated for either cemented or uncemented applications. Type of Use (Select one or both, as applicable) Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) # CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. "DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW." The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4} restor3d 4001 NC-54 Hwy Suite 3160 Durham, NC 27709 984.888.0593 # 510(k) Summary Date Prepared: July 1, 2026 This 510(k) Summary is being submitted in accordance with the requirements of 21 CFR 807.92. # A. 510(k) Owner: restor3d, inc. 4001 NC-54 Hwy, Suite 3160 Durham, NC 27709 # B. Primary Correspondent: Knox Pittman Regulatory Affairs Specialist II knox.pittman@restor3d.com # C. Premarket Notification: Submission Type: Traditional 510(k) Trade Name: Veritas Shoulder System Classification Name: Shoulder joint metal/polymer semi-constrained cemented prosthesis Regulation Number: 888.3660 Product Code: PHX, HSD Classification: II Review Panel: Orthopedic # D. Indications for Use: Reverse Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The restor3d rTSA System is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency. The patient specific components are only indicated for primary total shoulder replacement. restor3d K260556 Page 1 of 3 {5} restor3d 4001 NC-54 Hwy Suite 3160 Durham, NC 27709 984.888.0593 Glenoid components with porous surface are indicated for uncemented application with the addition of screw fixation. Note: A CT Scan is used to create the Veritas patient specific components Hemiarthroplasty Application of the Veritas Shoulder System: The Veritas Shoulder System is indicated for: Advanced wear and tear of the shoulder joint resulting from degenerative, post-traumatic, or rheumatoid arthritis if adequate bone stock is present. Avascular Necrosis Conditions consequent to earlier operations Humeral components with porous surface are indicated for either cemented or uncemented applications. # E. Predicate Devices: The subject Veritas Shoulder System is substantially equivalent to the following devices: | 510(k) | Trade Name | Manufacturer | | --- | --- | --- | | Primary Predicate Device | | | | K193099 | Anatomical Shoulder System | Zimmer Biomet | | Reference Device | | | | K243643 | Veritas Shoulder System *Previously cleared as restor3d Reverse Total Shoulder Replacement System* | restor3d | | K203375 | Revomotion *Previously cleared as OVOMotion Reverse Shoulder Arthroplasty System* | Arthrosurface | | K162455 | Humelock Reversed Shoulder | Fx Solutions | restor3d K260556 Page 2 of 3 {6} # restor3d 4001 NC-54 Hwy Suite 3160 Durham, NC 27709 984.888.0593 # F. Device Description: The Veritas Shoulder System Hemiarthroplasty line extension is an off-the-shelf system designed as a robust shoulder replacement for patients with glenoid and/or humeral bone defects. The subject components include the adaptor plate and the anatomic humeral head. The subject components are designed to mate with the previously cleared Veritas Shoulder System humeral stem component, cleared via K243643. The subject humeral head is affixed to the humeral stem component via the adapter plate, which features self-locking male tapers both proximally and distally. Additionally, the system includes supporting instrumentation to facilitate the surgical procedure. # G. Substantial Equivalence Comparison The Veritas Shoulder System Hemiarthroplasty application components, intended use, and indications for use are similar to the predicate device (Zimmer, Anatomical Shoulder System, K193099). The subject Veritas Shoulder System materials and manufacturing are identical to the reference device, Veritas Shoulder System (K243643). Differences in design of the subject device compared to the predicate are further supported since the subject Veritas Shoulder System performance is substantially equivalent to the reference devices Arthrosurface Revomotion (K203375) and Fx Solutions Humelock Reversed Shoulder (K162455). # H. Comparison of Performance The subject Veritas Shoulder System was subject to the following non-clinical performance tests to support the assertion of substantial equivalence: - Axial Taper Disassembly Strength per ASTM F2009 - Torsional Taper Disassembly Strength - Humeral Stem Fatigue - Fretting and Corrosion # I. Conclusions: In summary, based on the comparison of indications for use, intended use, and technological characteristics, as well as the performance testing conducted, the subject Veritas Shoulder System is shown to be substantially equivalent to the predicate Zimmer Anatomical Shoulder System (K193099). restor3d K260556 Page 3 of 3
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...